[1]
“A Quasi Experiment on Outcome of Mirabegron and Solifenacin in the Treatment of Primary Over Active Bladder in A Tertiary Hospital in Dhaka, Bangladesh”, Sir Salimullah Med. Coll. J., vol. 30, no. 1, pp. 55–60, Apr. 2022, doi: 10.3329/ssmcj.v30i1.59382.